-
Nifty, Sensex Up but Small-caps Weak– Wednesday Market Report
19 Nov 2025 20:22 GMT
… handling of alleged financial irregularities and suspected … Micro-Investment™, an industry-first feature enabling investments starting … entry for first-time investors. By lowering barriers, … FDA acceptance of the company’s explanations reinforces its …
-
Stocks Settle Higher Before Nvidia Earnings
19 Nov 2025 22:52 GMT
The S&P 500 Index ($SPX) (SPY) on Wednesday closed up by +0.38%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up by +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up by +0.56%. December E-mini S&P futures (ESZ25) rose +0.39%, and …
-
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First?
19 Nov 2025 22:52 GMT
… explosive growth to record investments in R&D … market whispers. Talk of a potential takeover has sent shares rallying, as investors … view of its financial health. The company reported a Q3 … late-stage pipeline and investing in partnerships meant to …
-
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward -- Hagens Berman
19 Nov 2025 20:53 GMT
… of Clinical Trials: Why Pharma Companies Must Be Accurate and How … the Firm Now: ATYR@hbsslaw.com
844-916-0895 Financial … Period, now covering investors who acquired shares between November 7, … Efzofitimod’s multi-billion-dollar market opportunity. “The suit …
-
As the FTSE falls I can see cheap stocks everywhere – time to go shopping!
19 Nov 2025 20:28 GMT
… , in-depth research, investing resources, and more. … I also write regular investment articles for The National … company is sinking due to its own mistakes rather than wider market … stocks is International Consolidated Airlines Group (LSE: IAG). Its shares …
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19 Nov 2025 21:01 GMT
PALO ALTO, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on November 17, 2025, the compensation …
-
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
19 Nov 2025 21:20 GMT
ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of …
-
With Office Utilization Climbing Globally, Companies Reconsider Downsizing
19 Nov 2025 22:00 GMT
New XY Sense Workplace Utilization Index shows APAC offices reach highest occupancy levels since pandemic, as North America posts strongest gains in five years.
MELBOURNE, AUSTRALIA, November 19, 2025 /EINPresswire.com/ -- The world's …
-
ACCESS Receivables Management Named One of the ‘Most Influential Companies of the Year 2025’ by The CEO Views
19 Nov 2025 21:00 GMT
Debt Collection Experts – Driving Results with Integrity and Innovation
HUNT VALLEY, MD, UNITED STATES, November 19, 2025 /EINPresswire.com/ -- The CEO Views has honored ACCESS Receivables Management, a leading full-service collection agency, as …
-
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
19 Nov 2025 22:49 GMT
… from investments in generative AI alone if the sector is … those technologies all across the pharmaceuticals industry.
“The business leaders … to, or an investor in, private companies like OpenAI and Anthropic … it comes to AI investing, citing two examples in …